Digoxin Monoclonal Antibody (4F6)
Size: 50μL, 100μL
Catalogue Numbers: RA10681-50, RA10681-100
Citations, Manuals and MSDS Available upon request.
Background: The most common indications for digoxin are atrial fibrillation and atrial flutter with rapid ventricular response, though beta blockers and/or calcium channel blockers are a better first choice. There is tentative evidence that digoxin may increase the risk of death, though another meta-analysis reports no change in mortality. High ventricular rate leads to insufficient diastolic filling time. By slowing down the conduction in the AV node and increasing its refractory period, digoxin can reduce the ventricular rate. The arrhythmia itself is not affected, but the pumping function of the heart improves, owing to improved filling.
Storage Instructions: -20°C/1 year
Applications: ELISA
Source: Mouse
Research Use Only